We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Fox Chase

News List

Fox Chase Researchers Find That Astrocytes Generated by Tumor Cells Contribute to SHH-Driven Medulloblastoma Relapse firstwordpharma
July 14, 2021
Researchers at Fox Chase Cancer Center have recently shown that sonic hedgehog-driven (SHH) medulloblastoma relapse may be prevented by targeting the transdifferentiation—a cell's ability to convert from one type of cell to another—of astrocytes.
Fox Chase Researcher Receives NIH Grant to Advance Treatment of Immune Diseases Using Genome Editing firstwordpharma
June 29, 2021
A Fox Chase Cancer Center researcher has received a grant of approximately half a million dollars from the National Institutes of Health (NIH) to identify disease-causing T cell defects.
Lantern Pharma and Fox Chase Cancer Center Collaborate contractpharma
September 23, 2020
Focus on advancing the development of LP-184 in pancreatic cancer.